MDS 2021 | Highlights of MDS 2021: promoting interactive learning

Irene Litvan • 22 Sep 2021

MDS 2021

Movement Disorders

Irene Litvan, MD, FAAN, FANA, University of California San Diego, La Jolla, CA, shares her thoughts on the recent virtual MDS 2021 congress, noting the benefits of the interactive format. Faculty discussions and participant Q&A sessions were a good opportunity to discuss issues in detail and gain insights from colleagues. This interview took place during the 2021 International Congress of Parkinson’s Disease and Movement Disorders.

Disclosures

Dr. Litvan’s research is supported by the National Institutes of Health grants: 2R01AG038791-06A, U01NS100610, U01NS80818, R25NS098999; U19 AG063911-1 and 1R21NS114764-01A1; the Michael J Fox Foundation, Parkinson Foundation, Lewy Body Association, CurePSP, Roche, Abbvie, Biogen, Centogene. EIP-Pharma, Biohaven Pharmaceuticals, Novartis, Brain Neurotherapy Bio and United Biopharma SRL – UCB. She was a member of the Scientific Advisory Board of Lundbeck and is a Scientific advisor for Amydis and Rossy Center for Progressive Supranuclear Palsy University of Toronto. She receives her salary from the University of California San Diego and as Chief Editor of Frontiers in Neurology.